We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
AdvaMed said the tax should be repealed so the industry can “make the multi-year investments in R&D and infrastructure necessary to sustain the innovation ecosystem.” Read More